Saturday, 31 October 2026European Markets

STRONGPOINT And FIDUCIAL OFF.SOL. Have A High Dividend Yield And Return On Equity In The Business Equipment & Supplies Industry.

Loading stream...

(vianews) - strongpoint (stro.ol) is among this list of stock assets with the highest dividend rate and return on equity on the business equipment & supplies industry.

financial asset price forward dividend yield return on equity
strongpoint (stro.ol) kr13.50 5.33% 4.94%
fiducial off.sol. (saci.pa) €27.80 1.67% 2.84%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. strongpoint (stro.ol)

5.33% forward dividend yield and 4.94% return on equity

strongpoint asa engages in the development, sale, and implementation of integrated technology solutions for stores and e-commerce operations in norway, sweden, and internationally. it offers various products and solutions comprising electronic shelf labels, scales and wrapping systems, and grocery robots; order and in-store picking, home delivery, grocery lockers, drive-through, and autostore microfulfilment solutions; cash management systems; and shop fitting services, as well as other retail technology and self-checkout solutions. the company also provides shopflow logistics, a cloud based mobile logistics system for handling routines that include receiving goods, inventory, balance adjustment, ordering labels printing, and waste management; and vensafe, which automates in-store sales of restricted and theft-prone products. it has a strategic partnership with halodi robotics to develop robotic solutions for the grocery retail sector. the company was formerly known as psi group asa and changed its name to strongpoint asa in september 2015. strongpoint asa was incorporated in 2000 and is headquartered in rælingen, norway.

earnings per share

as for profitability, strongpoint has a trailing twelve months eps of kr0.14.

pe ratio

strongpoint has a trailing twelve months price to earnings ratio of 96.43. meaning, the purchaser of the share is investing kr96.43 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.94%.

moving average

strongpoint's value is way below its 50-day moving average of kr17.76 and way under its 200-day moving average of kr21.13.

volume

today's last reported volume for strongpoint is 40413 which is 12.89% above its average volume of 35797.

more news about strongpoint.

2. fiducial off.sol. (saci.pa)

1.67% forward dividend yield and 2.84% return on equity

fiducial office solutions distributes office supplies and furniture products in france. the company was founded in 1949 and is headquartered in courbevoie, france. fiducial office solutions operates as a subsidiary of fiducial sofiral.

earnings per share

as for profitability, fiducial off.sol. has a trailing twelve months eps of €0.87.

pe ratio

fiducial off.sol. has a trailing twelve months price to earnings ratio of 31.95. meaning, the purchaser of the share is investing €31.95 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.84%.

revenue growth

year-on-year quarterly revenue growth grew by 5.6%, now sitting on 221.26m for the twelve trailing months.

volume

today's last reported volume for fiducial off.sol. is 2 which is 100% above its average volume of 1.

yearly top and bottom value

fiducial off.sol.'s stock is valued at €27.80 at 06:40 est, below its 52-week high of €28.20 and higher than its 52-week low of €27.60.

more news about fiducial off.sol..

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com